Drugs / TLN-372
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07204340 | Sep 2025 → Dec 2031 expected | — | Treeline Biosciences, Inc. | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TLN-372 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07204340 ↗ |